Literature DB >> 10388760

Modulation of nanotube formation by structural modifications of sphingolipids.

V S Kulkarni1, J M Boggs, R E Brown.   

Abstract

Galactosylceramides (GalCers) containing nervonoyl (24:1(Delta15(cis))) acyl chains have the capacity to assemble into nanotubular microstructures in excess water (. Biophys. J. 69:1976-1986). To define the structural parameters that modulate nanotube formation, GalCer derivatives were synthesized that contained cis monounsaturated acyl chains with the formula X:1((X-9)). X indicates the total acyl carbon number (24, 22, 20, or 18), and 1 indicates a single cis double bond, the location of which is designated by the superscript (X-9). Deep etching of freeze-fractured 24:1(Delta15(cis)) GalCer dispersions followed by replica production and transmission electron microscopic analysis confirmed nanotube morphology (25-30-nm diameter). Control experiments revealed that tubule formation was promoted by cooling through the main enthalpic phase transition coupled with repetitive freeze-thaw cycling. Imparting a negative charge to the sugar headgroup of 24:1(Delta15)GalCer via sulfate dramatically altered mesomorpholgy and resulted in myelinic-like, multilamellar structures. Removal of the sugar headgroup (24:1(Delta15)Cer) resulted in flattened cylindrical structures with a cochleate appearance. Compared to these large-scale changes in morphology, more subtle changes were induced by structural changes in the acyl chain of 24:1(Delta15)GalCer. 22:1(Delta13)GalCer dispersions consisted of long, smooth tubules (35-40-nm diameters) with a strong tendency to self-align into bundle-like aggregates. In contrast, the microstructures formed by 20:1(Delta11)GalCer resembled helical ribbons with a right-handed twist. Ribbon widths averaged 30-35 nm, with helical pitches of 80-90 nm. 18:1(Delta9)GalCer displayed a variety of morphologies, including large-diameter multilamellar cylinders and liposome-like structures, as well as stacked, plate-like arrays. The results are discussed within the context of current theories of lipid tubule formation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10388760      PMCID: PMC1300332          DOI: 10.1016/S0006-3495(99)76892-X

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  28 in total

1.  A new twist on protein crystallization.

Authors:  S A Darst
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

2.  The interfacial elastic packing interactions of galactosylceramides, sphingomyelins, and phosphatidylcholines.

Authors:  J M Smaby; V S Kulkarni; M Momsen; R E Brown
Journal:  Biophys J       Date:  1996-02       Impact factor: 4.033

3.  Preparative scale isolation of sphingosine.

Authors:  N S Radin
Journal:  J Lipid Res       Date:  1990-12       Impact factor: 5.922

4.  Tubules of globoid leukodystrophy: a right-handed helix.

Authors:  E J Yunis; R E Lee
Journal:  Science       Date:  1970-07-03       Impact factor: 47.728

5.  The effects of cerebrosides on model membrane shape.

Authors:  W Curatolo; L J Neuringer
Journal:  J Biol Chem       Date:  1986-12-25       Impact factor: 5.157

6.  Fragmentation into small vesicles of dioleoylphosphatidylcholine bilayers during freezing and thawing.

Authors:  R C MacDonald; F D Jones; R Qiu
Journal:  Biochim Biophys Acta       Date:  1994-05-11

7.  Microstructural polymorphism in bovine brain galactocerebroside and its two major subfractions.

Authors:  D D Archibald; P Yager
Journal:  Biochemistry       Date:  1992-09-22       Impact factor: 3.162

8.  Diacetylenic lipid tubules: experimental evidence for a chiral molecular architecture.

Authors:  J M Schnur; B R Ratna; J V Selinger; A Singh; G Jyothi; K R Easwaran
Journal:  Science       Date:  1994-05-13       Impact factor: 47.728

Review 9.  Phases and phase transitions of the sphingolipids.

Authors:  R Koynova; M Caffrey
Journal:  Biochim Biophys Acta       Date:  1995-04-06

10.  Macro-ripple phase formation in bilayers composed of galactosylceramide and phosphatidylcholine.

Authors:  R E Brown; W H Anderson; V S Kulkarni
Journal:  Biophys J       Date:  1995-04       Impact factor: 4.033

View more
  7 in total

1.  Trans interactions between galactosylceramide and cerebroside sulfate across apposed bilayers.

Authors:  J M Boggs; A Menikh; G Rangaraj
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

2.  Structure of core domain of fibril-forming PHF/Tau fragments.

Authors:  Hideyo Inouye; Deepak Sharma; Warren J Goux; Daniel A Kirschner
Journal:  Biophys J       Date:  2005-12-09       Impact factor: 4.033

3.  Nanotubules formed by highly hydrophobic amphiphilic alpha-helical peptides and natural phospholipids.

Authors:  Tomomi Furuya; Taira Kiyota; Sannamu Lee; Tohru Inoue; Gohsuke Sugihara; Anna Logvinova; Paul Goldsmith; H Michael Ellerby
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

Review 4.  A glycosynapse in myelin?

Authors:  Joan M Boggs; Huimin Wang; Wen Gao; Dina N Arvanitis; Yanping Gong; Weixian Min
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

5.  Membrane domain formation, interdigitation, and morphological alterations induced by the very long chain asymmetric C24:1 ceramide.

Authors:  Sandra N Pinto; Liana C Silva; Rodrigo F M de Almeida; Manuel Prieto
Journal:  Biophys J       Date:  2008-06-27       Impact factor: 4.033

6.  Undulating tubular liposomes through incorporation of a synthetic skin ceramide into phospholipid bilayers.

Authors:  Peng Xu; Grace Tan; Jia Zhou; Jibao He; Louise B Lawson; Gary L McPherson; Vijay T John
Journal:  Langmuir       Date:  2009-09-15       Impact factor: 3.882

7.  Formation of tubules and helical ribbons by ceramide phosphoethanolamine-containing membranes.

Authors:  Takehiko Inaba; Motohide Murate; Nario Tomishige; Yan-Fen Lee; Françoise Hullin-Matsuda; Brigitte Pollet; Nicolas Humbert; Yves Mély; Yasushi Sako; Peter Greimel; Toshihide Kobayashi
Journal:  Sci Rep       Date:  2019-04-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.